M. Schlesinger

701 total citations
48 papers, 516 citations indexed

About

M. Schlesinger is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, M. Schlesinger has authored 48 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 11 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in M. Schlesinger's work include Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (12 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). M. Schlesinger is often cited by papers focused on Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (12 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). M. Schlesinger collaborates with scholars based in Israel and United States. M. Schlesinger's co-authors include Uri Galili, R Rabinowitz, Reuven Laskov, Anthony Russell, H. H. Storch, Haim Giloh, Zichria Zakay‐Rones, R. B. Anderson, Chana Gabay and Deborah Abrams Kaplan and has published in prestigious journals such as Science, Neurology and JNCI Journal of the National Cancer Institute.

In The Last Decade

M. Schlesinger

47 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Schlesinger Israel 14 216 94 60 57 49 48 516
Ernst R. Waelti Switzerland 15 131 0.6× 187 2.0× 50 0.8× 153 2.7× 49 1.0× 30 663
Ruth Tyler United States 13 194 0.9× 196 2.1× 146 2.4× 25 0.4× 21 0.4× 18 625
Masahide Kuroki Japan 7 118 0.5× 115 1.2× 48 0.8× 30 0.5× 48 1.0× 10 418
Orfanos Ce Germany 14 101 0.5× 133 1.4× 48 0.8× 97 1.7× 71 1.4× 53 683
Alan M. Appel United States 10 125 0.6× 72 0.8× 14 0.2× 16 0.3× 37 0.8× 16 575
Melissa Petreaca United States 8 98 0.5× 208 2.2× 39 0.7× 58 1.0× 19 0.4× 10 673
Arlette De Coninck Belgium 10 111 0.5× 98 1.0× 27 0.5× 44 0.8× 21 0.4× 13 422
A. Bijma Netherlands 12 48 0.2× 82 0.9× 18 0.3× 32 0.6× 56 1.1× 20 477
Zygmunt Mackiewicz Lithuania 12 84 0.4× 83 0.9× 133 2.2× 45 0.8× 20 0.4× 29 498
Masato KUWABARA Japan 12 148 0.7× 178 1.9× 17 0.3× 44 0.8× 38 0.8× 34 477

Countries citing papers authored by M. Schlesinger

Since Specialization
Citations

This map shows the geographic impact of M. Schlesinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Schlesinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Schlesinger more than expected).

Fields of papers citing papers by M. Schlesinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Schlesinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Schlesinger. The network helps show where M. Schlesinger may publish in the future.

Co-authorship network of co-authors of M. Schlesinger

This figure shows the co-authorship network connecting the top 25 collaborators of M. Schlesinger. A scholar is included among the top collaborators of M. Schlesinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Schlesinger. M. Schlesinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gazit, Roi, et al.. (2008). Immunological assessment of familial tinea corporis. Journal of the European Academy of Dermatology and Venereology. 22(7). 871–874. 9 indexed citations
2.
Yu, Ying, et al.. (2002). Hyposialated 185 kDa CD45RA+ molecules attain a high concentration in B lymphoma cells and in activated human B cells. European Journal Of Haematology. 68(1). 22–30. 10 indexed citations
3.
Gabay, Chana, et al.. (1999). Somatic mutations and intraclonal variations in the rearranged Vk genes of B‐non‐Hodgkin's lymphoma cell lines. European Journal Of Haematology. 63(3). 180–191. 27 indexed citations
4.
Nagler, Arnon, Reba Condiotti, R Rabinowitz, et al.. (1999). Detection of minimal residual disease (MRD) after bone marrow transplantation (BMT) by multi-parameter flow cytometry (MPFC). Medical Oncology. 16(3). 177–187. 17 indexed citations
5.
Freier, S., et al.. (1998). Hereditary CD4+ T lymphocytopenia. Archives of Disease in Childhood. 78(4). 371–372. 22 indexed citations
6.
Giloh, Haim, et al.. (1996). Preferential cytotoxic effect of Newcastle disease virus on lymphoma cells. Journal of Cancer Research and Clinical Oncology. 122(7). 409–415. 26 indexed citations
7.
Shubinsky, George & M. Schlesinger. (1994). The effects of interleukin 4 on the cell cycle of a human B‐cell lymphoma line. Cell Proliferation. 27(8). 489–499. 1 indexed citations
8.
Schlesinger, M., et al.. (1993). Psychosocial Stress and NK Cells among Members of a Communal Settlement. Advances in experimental medicine and biology. 335. 247–254. 7 indexed citations
9.
Marschall, Katherine E., M. Schlesinger, Herman Turndorf, & Margarita M. Puig. (1989). Beta-endorphin and ACTH levels in the perioperative period. General Pharmacology The Vascular System. 20(4). 399–402. 6 indexed citations
10.
Rabinowitz, R, Rivka Hadar, Reuven Laskov, & M. Schlesinger. (1986). A new autoreactive monoclonal antibody specific for the Thy-1 antigen.. PubMed. 8(5). 279–94. 2 indexed citations
11.
Rabinowitz, R, Joel V. Weinstock, Ehud J. Margalioth, Hannah Ben‐Bassat, & M. Schlesinger. (1982). Antigens specific for human T-lymphocytes detected by xenoantisera to HD-MAR cells: Their differential expression on various T-cell lines. Human Immunology. 4(3). 219–228. 3 indexed citations
12.
Schlesinger, M. & J. George Bekesi. (1977). Natural Autoantibodies Cytotoxic for Thymus Cells and for Neuraminidase-Treated Leukemia Cells in the Sera of Normal AKR Mice 2. JNCI Journal of the National Cancer Institute. 59(3). 945–950. 10 indexed citations
13.
Schlesinger, M.. (1976). Cell Surface Receptors and Lymphocyte Migration. Immunological Communications. 5(9). 775–793. 10 indexed citations
14.
Schlesinger, M., E Israël, M. Chaouat, & Igal Gery. (1975). THE NATURE AND FUNCTION OF T‐CELL ANTIGENS. Annals of the New York Academy of Sciences. 249(1). 505–522. 3 indexed citations
15.
Galili, Uri & M. Schlesinger. (1975). Studies on the formation of E-rosettes by human T lymphocytes and thymus cells. Effects of temperature, metabolic inhibitors and anti-T sera.. PubMed. 11(12). 1357–67. 11 indexed citations
16.
Schlesinger, M., et al.. (1973). Thymus cell subpopulations separated on discontinuous BSA gradients: Antigenic properties and circulation capacity. Cellular Immunology. 6(1). 49–58. 16 indexed citations
17.
Laskov, Reuven, R Rabinowitz, & M. Schlesinger. (1973). Antigenic characterization of murine rosette and plaque-forming cells.. PubMed. 24(6). 939–54. 12 indexed citations
18.
Schlesinger, M., et al.. (1969). Characterization of cytotoxic isoantisera produced in RIII mice. II. Serological properties of antiserum fractions.. PubMed. 5(2). 235–44. 2 indexed citations
19.
Anderson, R. B., et al.. (1957). Hydrogenating Coal at 800° C.. Industrial & Engineering Chemistry. 49(12). 2008–2010. 22 indexed citations
20.
Schlesinger, M., et al.. (1955). Upgrading Fischer-Tropsch Products. Industrial & Engineering Chemistry. 47(10). 2104–2108. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ernst R. Waelti Breakdown of academic impact, for papers by Ruth Tyler Breakdown of academic impact, for papers by Masahide Kuroki Breakdown of academic impact, for papers by Orfanos Ce Breakdown of academic impact, for papers by Alan M. Appel Breakdown of academic impact, for papers by Melissa Petreaca Breakdown of academic impact, for papers by Arlette De Coninck Breakdown of academic impact, for papers by A. Bijma Breakdown of academic impact, for papers by Zygmunt Mackiewicz Breakdown of academic impact, for papers by Masato KUWABARA
Rankless by CCL
2026